Anzeige
Mehr »
Login
Samstag, 23.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire-Archiv vom 28.02.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
28.02.Nasdaq Stockholm AB: Listing of bond loan issued by Diös Fastigheter AB on STO Sustainable Commercial Paper (132/24)358Nasdaq Stockholm decides to list 1 bond loan issued by Diös Fastigheter AB with effect from 2024-02-29. Last day of trading is set to 2024-05-29. The instrument will be listed on STO Sustainable Commercial...
► Artikel lesen
28.02.Nasdaq Stockholm AB: Listing of bond loan issued by Vasakronan AB on STO Sustainable Commercial Paper (131/24)340Nasdaq Stockholm decides to list 1 bond loan issued by Vasakronan AB with effect from 2024-02-29. Last day of trading is set to 2024-06-28. The instrument will be listed on STO Sustainable Commercial...
► Artikel lesen
28.02.Nasdaq Stockholm AB: Delisting of warrants issued by Morgan Stanley & Co. International plc (21/24)237As of February 29, 2024, the following warrants issued by Morgan Stanley & Co. International plc will be delisted upon request from the issuer. Short ISIN BEAR AXFO X5 AVA 7 GB00BNTT3767 BEAR...
► Artikel lesen
28.02.Nasdaq Stockholm AB: Delisting of warrants issued by Morgan Stanley & Co. International plc (20/24)261As of February 29, 2024, the following warrants issued by Morgan Stanley & Co. International plc will be delisted upon request from the issuer. Short ISIN MINI S KAMBI AVA 14 GB00BNV2P229 MINI...
► Artikel lesen
28.02.Nasdaq Stockholm AB: Instruction for notifications to Nasdaq Surveillance regarding extraordinary information (1/24)181According to item 3.12 in Nasdaq Nordic Main Market Rulebook for Issuers of Shares an issuer which intends to disclose information that is assumed to be of extraordinary importance for the issuer or...
► Artikel lesen
28.02.Nasdaq Copenhagen A/S: Genmab A/S - admittance to trading and official listing of new shares due to employee warrant exercise334The share capital of Genmab A/S has been increased. The admittance to trading and official listing will take effect as per 1 March 2024 in the ISIN below. ISIN: DK0010272202 ...
► Artikel lesen
28.02.NASDAQ OMX Nordic: Risk Management 5/24199New parameters will apply from March 4, 2024 Nasdaq Derivatives Markets has decided to make changes to the Parameter Value List, see Appendix 13 in Nasdaq Derivatives Markets Rules & Regulations. See attached...
► Artikel lesen
28.02.Nasdaq Stockholm AB: Delisting of Re:NewCell AB from Nasdaq First North Premier Growth Market (98/24)545On February 26, 2024, Re:NewCell AB was declared bankrupt by the Stockholm District Court. According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the exchange may decide to delist...
► Artikel lesen
28.02.Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Xbrane Biopharma AB (21/24)444With effect from February 29, 2024, the unit rightsin Nasdaq will be traded on the list for Equity rights. Trading will continue up until and including March 08, 2024. Instrument: Unit rights ...
► Artikel lesen
28.02.First North Iceland: Solid Clouds hf. - Increase in share capital158With reference to announcements made public by Solid Clouds hf. (symbol: SOLID) on February 27 2024, the total nominal value of the company's listed share capital on First North Iceland will be increased...
► Artikel lesen
28.02.Exchange announcement on the results of domestic GMTN notes primary placement competitive auction204ISIN code of the security XS2549862758 Fixed income (coupon) rate (%) 3.875% Maturity date 25.03.2027 Date of competitive multi-price...
► Artikel lesen
28.02.Nasdaq Stockholm AB: Xbrane Biopharma AB ges observationsstatus / Xbrane Biopharma AB receives observation status (20/24)354Den 26 februari 2024 offentliggjorde Xbrane Biopharma AB ("Bolaget") dess bokslutskommuniké för 2023 med information om Bolagets finansiella ställning. Den 27 februari 2024 offentliggjorde Bolaget...
► Artikel lesen